Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Pilocarpine for Opioid-Induced Dry Mouth
NCT00003686Phase 3Terminated
- Sponsor
- Canadian Cancer Trials Group
- Start
- May 1998
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pilocarpine in xerostomia, sponsored by Canadian Cancer Trials Group. Started May 1998; status: terminated.
02
Drugs
pilocarpine
03
Conditions
xerostomia
Beyond the preview
Go deeper on NCT00003686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003686.